ASPSCR1, through its fusion with TFE3, plays a pivotal role in the development of alveolar soft part sarcoma by acting as an aberrant transcriptional transactivator, leading to deregulated transcription and oncogenesis (46). This evidence concerns the gene ASPSCR1 and alveolar soft part sarcoma.